Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/05/28/2888873/0/en/Foghorn-Therapeutics-to-Participate-in-Upcoming-Investor-Conferences-in-June.html
https://www.globenewswire.com/news-release/2024/05/22/2886922/0/en/Foghorn-Therapeutics-Raises-Approximately-110-Million-Through-Registered-Direct-Offering-to-Advance-Pipeline.html
https://www.globenewswire.com/news-release/2024/05/20/2884788/0/en/Foghorn-Announces-Pricing-of-Registered-Direct-Offering-of-Common-Stock-and-Pre-Funded-Warrants.html
https://www.globenewswire.com/news-release/2024/05/06/2875677/0/en/Foghorn-Therapeutics-Provides-First-Quarter-2024-Financial-and-Corporate-Update.html
https://www.globenewswire.com/news-release/2024/04/16/2863450/0/en/Foghorn-Therapeutics-Strengthens-Financial-Leadership-with-Appointment-of-Kristian-Humer-as-Chief-Financial-Officer.html
https://www.globenewswire.com/news-release/2024/04/09/2860383/0/en/Foghorn-Therapeutics-Presents-New-Preclinical-Data-on-Potential-First-in-Class-BRM-Selective-Inhibitor-FHD-909-and-Selective-CBP-and-Selective-EP300-Degrader-Oncology-Programs.html
https://www.globenewswire.com/news-release/2024/04/05/2858433/0/en/Foghorn-Therapeutics-to-Participate-in-Needham-s-23rd-Annual-Virtual-Healthcare-Conference.html
https://www.globenewswire.com/news-release/2024/03/26/2852216/0/en/Foghorn-to-Host-Conference-Call-and-Webcast-on-Pipeline-of-Potential-First-in-Class-Medicines-in-Conjunction-with-the-2024-AACR-Annual-Meeting.html
https://www.globenewswire.com//news-release/2024/03/07/2842094/0/en/Foghorn-Therapeutics-Provides-Financial-Update-for-2023-and-2024-Strategic-Outlook.html
https://www.globenewswire.com//news-release/2024/03/05/2840970/0/en/Foghorn-Therapeutics-to-Present-New-Preclinical-Data-at-2024-AACR-Annual-Meeting-Reflecting-Advances-with-Multiple-Potential-First-in-Class-Medicines-Including-the-Selective-Inhibi.html